Position in TRAW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$870,914
New position
Shares Held
24,616
first reported quarter
Ownership
0.160%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2
of 35 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GTS SECURITIES LLC holds $6,120,803 across 20 Biotechnology names. TRAW ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,164 | $1,079,924 | |
| 2 | GMAB |
Genmab A/S
|
32,116 | $882,226 | |
| 3 | TRAW |
Traws Pharma, Inc.
This page
|
24,616 | $870,914 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,452 | $437,095 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
25,320 | $430,440 | |
| 7 | TLX |
Telix Pharmaceuticals Ltd
|
35,537 | $409,741 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 |
No Holdings History
No holdings records found for this institution in TRAW.